USD 18.26
(-3.13%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 65.54 Million USD | 0.12% |
2022 | 66.27 Million USD | 4.59% |
2021 | 63.36 Million USD | 18.21% |
2020 | 53.6 Million USD | 29.69% |
2019 | 41.33 Million USD | 21.46% |
2018 | 33.6 Million USD | 32.86% |
2017 | 25.11 Million USD | 49.77% |
2016 | 17.07 Million USD | 304.45% |
2015 | 4.19 Million USD | 874.19% |
2014 | -546.12 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 17.18 Million USD | -3.88% |
2024 Q3 | 19.18 Million USD | -33.43% |
2024 Q1 | 18.98 Million USD | 47.74% |
2023 Q4 | 19.92 Million USD | 1.04% |
2023 FY | - USD | 0.12% |
2023 Q2 | 20.22 Million USD | 230.38% |
2023 Q1 | 6.12 Million USD | -64.07% |
2023 Q3 | 19.71 Million USD | -2.55% |
2022 Q3 | 16.93 Million USD | 1.79% |
2022 Q1 | 16.29 Million USD | -1.58% |
2022 FY | - USD | 4.59% |
2022 Q2 | 16.63 Million USD | 2.11% |
2022 Q4 | 17.04 Million USD | 0.63% |
2021 Q3 | 16.2 Million USD | 0.07% |
2021 Q1 | 15.03 Million USD | 3.59% |
2021 FY | - USD | 18.21% |
2021 Q2 | 16.19 Million USD | 7.67% |
2021 Q4 | 16.55 Million USD | 2.17% |
2020 FY | - USD | 29.69% |
2020 Q4 | 14.51 Million USD | 5.39% |
2020 Q3 | 13.77 Million USD | 4.83% |
2020 Q2 | 13.13 Million USD | 4.81% |
2020 Q1 | 12.53 Million USD | 4.0% |
2019 FY | - USD | 21.46% |
2019 Q4 | 12.05 Million USD | 9.35% |
2019 Q3 | 11.02 Million USD | 13.22% |
2019 Q2 | 9.73 Million USD | 11.26% |
2019 Q1 | 8.75 Million USD | 141.45% |
2018 Q2 | 8.85 Million USD | 7.06% |
2018 Q1 | 8.27 Million USD | 7.4% |
2018 Q3 | 8.56 Million USD | -3.25% |
2018 Q4 | 3.62 Million USD | -57.71% |
2018 FY | - USD | 32.86% |
2017 Q3 | 6.33 Million USD | 4.42% |
2017 Q4 | 7.7 Million USD | 21.61% |
2017 FY | - USD | 49.77% |
2017 Q1 | 5.5 Million USD | 10.56% |
2017 Q2 | 6.06 Million USD | 10.13% |
2016 Q1 | 3.4 Million USD | 23.75% |
2016 Q4 | 4.98 Million USD | 3.64% |
2016 FY | - USD | 304.45% |
2016 Q3 | 4.8 Million USD | 18.34% |
2016 Q2 | 4.06 Million USD | 19.4% |
2015 Q4 | 2.74 Million USD | 16.98% |
2015 FY | - USD | 874.19% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | -891 Thousand USD | 0.0% |
2015 Q3 | 2.35 Million USD | 363.75% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
American Healthcare REIT, Inc. | 324.26 Million USD | 79.788% |
CareTrust REIT, Inc. | 215.13 Million USD | 69.535% |
Healthpeak Properties, Inc. | 1.18 Billion USD | 94.49% |
Global Medical REIT Inc. | 111.67 Million USD | 41.312% |
Global Medical REIT Inc. | 111.67 Million USD | 41.312% |
Healthcare Realty Trust Incorporated | 1.57 Billion USD | 95.841% |
LTC Properties, Inc. | 127.37 Million USD | 48.545% |
Medical Properties Trust, Inc. | 684.64 Million USD | 90.427% |
National Health Investors, Inc. | 249.02 Million USD | 73.681% |
Omega Healthcare Investors, Inc. | 810.84 Million USD | 91.917% |
Sila Realty Trust, Inc. | 144.97 Million USD | 54.792% |
Universal Health Realty Income Trust | 27.73 Million USD | -136.325% |
Ventas, Inc. | 1.83 Billion USD | 96.42% |
Welltower Inc. | 2.35 Billion USD | 97.222% |